Loading…
Cytotoxicity Activity of Some meso‐Dihydroguaiaretic Acid Derivatives and Mode of Action of the Most Active Compound
The aim of this study was to screen sixteen meso‐1 semi‐synthetic derivatives bearing ether, esther, carbamate, phosphate or aminoether functional groups against five cancer cell lines: MCF‐7 (breast), A549 (lung), HepG2 (liver), HeLa (cervix), and DU145 (prostate) at 25 μM using the MTT assay. Resu...
Saved in:
Published in: | Chemistry & biodiversity 2024-02, Vol.21 (2), p.e202301930-n/a |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The aim of this study was to screen sixteen meso‐1 semi‐synthetic derivatives bearing ether, esther, carbamate, phosphate or aminoether functional groups against five cancer cell lines: MCF‐7 (breast), A549 (lung), HepG2 (liver), HeLa (cervix), and DU145 (prostate) at 25 μM using the MTT assay. Results from the screening showed that two derivatives had the lowest percentage of cell viability at 25 μM, the aminoether derivative meso‐11 and the esther derivative meso‐20 against A549 (44.15±0.78 %) and MCF‐7 (41.60±0.92 %), respectively. Then, it was determined the IC50 value of each compound against their most sensitive cancer cell line. Results showed that aminoether derivative meso‐11 showed potent cytotoxicity against A549 (IC50=17.11±2.11 μM), whereas it resulted more cytotoxic against the LL‐47 lung normal cell line (IC50=9.49±1.19 μM) having a Selective Index (SI) of 0.55. On the other hand, the esther derivative meso‐20 exhibited potent activity against MCF‐7 (IC50=18.20±1.98 μM), whereas it displayed moderate cytotoxicity against the MCF‐10 breast normal cell line (IC50=41.22±2.17 μM) with a SI of 2.2. Finally, studies on the mechanism of action of meso‐20 indicated disruption of MCF‐7 plasma membrane in vitro and the AMPK activation in silico. |
---|---|
ISSN: | 1612-1872 1612-1880 |
DOI: | 10.1002/cbdv.202301930 |